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ABSTRACT: The present paper is intended to be a comprehensive assessment and
rationalization, from a statistical mechanics perspective, of existing alchemical theories for
binding free energy calculations of ligand−receptor systems. In detail, the statistical
mechanics foundation of noncovalent interactions in ligand−receptor systems is revisited,
providing a unifying treatment that encompasses the most important variants in the
alchemical approaches from the seminal double annihilation method [Jorgensen et al. J.
Chem. Phys. 1988; 89, 3742] to the double decoupling method [Gilson et al. Biophys. J.
1997; 72, 1047] and the Deng and Roux alchemical theory [Deng and Roux J. Chem.
Theory Comput. 2006; 2, 1255]. Connections and differences between the various
alchemical approaches are highlighted and discussed.
■ INTRODUCTION
The determination of the binding free energy in ligand−
receptor systems is the cornerstone of drug discovery. In the
last few decades, traditional molecular docking techniques in
computer-assisted drug design have been modified, integrated,
or superseded using methodologies relying on a more realistic
description of the drug−receptor system. It has become
increasingly clear that a microscopic description of the solvent
is a crucial ingredient to reliably rank the affinity of putative
ligands for a given target.1,2 In the framework of atomistic
molecular dynamics (MD) simulations with explicit solvent,
several methods for rigorously determining the absolute
binding free energy in noncovalently bonded systems have
been devised. Most of these methodologies are based on the so-
called alchemical route3−5 (see refs 6−9 for recent reviews). In
this approach, proposed for the first time by Jorgensen et
al.10,11 and named double annihilation method (DAM), the
absolute binding free energy of the ligand−receptor system was
obtained by setting up a thermodynamic cycle as indicated in
Figure 1 in which the basic quantities to be estimated are the
annihilation or decoupling free energies of the ligand in the
bound state and in bulk water, indicated hereafter as ΔGb and
ΔGu, respectively. These decoupling free energies correspond
to the two closing branches of the cycle and are obtained by
discretizing the alchemical path connecting the fully interacting
and fully decoupled ligand in a number of intermediate
nonphysical states and then running MD simulations for each
of these states.
Alchemical states are defined by a λ coupling parameter
entering the Hamiltonian, varying between 1 and 0, such that at
λ = 1 and λ = 0 one has the fully interacting and gas-phase
ligand, respectively. ΔGb and ΔGu are usually recovered as a
sum of the contributions from each of the λ windows by
applying the free energy perturbation method12 (FEP).
Alternatively, and equivalently, one can compute the canonical
average of the derivative of the Hamiltonian at the discrete λ
points, obtaining the decoupling free energy via numerical
thermodynamic integration (TI).13 Finally, the thermodynamic
cycle is closed by computing the difference between the two
decoupling free energies along the alchemical path, ΔGb and
ΔGu, obtaining the dissociation free energy in solution.
Gilson et al.14 criticized Jorgensen’s theory10 by pointing out
that the resulting dissociation free energy does not depend
upon the choice of standard concentration. To define a
reference chemical potential for the decoupling ligand when
bound to the receptor, Gilson introduced a “restraint” that
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Figure 1. Alchemical thermodynamic cycle for computing the absolute
dissociation free energy, ΔG0, in ligand−receptor systems. The
subscripts “sol” and “gas” indicate solvated and gas-phase (decoupled)
species, respectively. The ligand−environment interactions must be
turned off in the solvated complex and in bulk solvent, obtaining ΔG0
= ΔGb − ΔGu.
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keeps the ligand in a volume Vr around the binding place. This
restraint is shown to yield14−16 an additive standard state-
dependent correction to the dissociation free energy of kBT
ln(Vr/V
0), interpreted as a chemical potential difference of the
ligand at a concentration 1/Vr and at the standard
concentration 1/V0. Gilson et al. named this variant of DAM
the double decoupling method (DDM). According to Gilson,
the effect of progressively strengthening the restraint,17 leading
to a more negative correction, should be balanced by a larger
work integral so that “errors will occur only when the
integration region defined by the restraint volume becomes
so small that conformations that ought to make important
contributions to the work integral are missed.”
DDM was further developed by Karplus and co-workers15
who introduced a versatile set of harmonic restraints to be used
in MD simulations, restricting both the position and the
orientation of the ligand.
Hamelberg and McCammon18 posed the “questions as to
how sensitive are the calculated free energies to the strength of
the restraining potentials and whether an arbitrary choice of the
restraint potential would yield the correct results”. The recipe
they proposed is to set the force constant in the harmonic
restraining potential according to the mean fluctuation of the
restrained coordinate in a preliminary unrestrained simulation.
Subsequently, Deng and Roux19 elaborated a DDM variant
whereby the standard state correction “in the strong restraint
limit” is no longer dependent on the imposed restraint volume
Vr, hence resolving the alluded inconsistency
17,20 in the Gilson
theory. However, it does apparently require the estimate of an
unknown translational, rotational, and conformational binding
site volume Vsite in the complex
21 via an independent
unrestrained simulation of the bound state or via an auxiliary
FEP for turning on the restraint when the fully coupled ligand
is in the binding site.19,22,23
In a series of recent papers, Fujitani and co-workers,24−27 in
their “Massively Parallel Computation of Absolute Binding Free
Energy (MP-CAFEE)”, successfully applied the unrestrained
DAM approach to several drug−receptor systems, in many
cases accurately predicting the experimental dissociation free
energy via FEP. Most importantly, these authors directly
compared their DAM/FEP values, ΔGbind = ΔGu − ΔGb, to the
experimental value ΔG0, openly criticizing the DDM standard
state correction:25 “as far as we know there is no theoretical or
experimental proof that [the standard state corrected] ΔG0
meets the definition of the absolute binding energy.[..]
Therefore, we directly compare ΔGbind with ΔG0.”
The standard state correction issue can be bypassed
altogether by computing relative binding free energies3,28 due
to the transmutation of an unrestrained ligand into another in
the same binding site and in the solvent. Relative binding free
energy calculations neglect altogether the possibility of a change
of binding site volume due to the transmutation or even the
possibility that the transmuting ligand may leave the binding
site at some alchemical state. This approach is hence limited to
the assessment of binding affinities in strictly congeneric series
of ligands with the tacit assumption of a constant binding site
volume upon transmutation.
In conclusion, the question of the standard state correction
or, equivalently, the issue of the binding site volume in drug−
receptor dissociation free energy calculations is either ignored,
as in calculations of relative free energies, or treated using
methodologies relying on the definition of arbitrary sets of
constraints whose effects on the resulting free energy have
never been convincingly assessed. In any case, the standard
state issue and the strictly connected binding site volume
definition that is indeed crucial for a reliable MD-based tool in
drug discovery, is still far from being settled. In this
contribution, we try to address these issues, revisiting the
DAM and DDM theories with a spotlight on the relationship
between the binding site, restraint, and standard state volumes
in noncovalent association, providing a unifying treatment
encompassing Jorgensen, Gilson, and Deng and Roux theories.
Corpora Non Agunt Nisi Fixata:29 Alchemical Theory
with Restraints. Molecular recognition in host−guest or
drug−receptor noncovalent interactions is based on highly
specific molecular complementation,30 translated as the
existence of a single overwhelmingly prevalent binding
“pose”. The latter can be defined using an appropriate set of
coordinates that are functions of the ligand and receptor
Cartesian coordinates x. A natural coordinate in ligand−
receptor binding is represented by the vector R connecting the
center of mass (COM) of the ligand to the COM of the
receptor. The vector R defines the precise location of the ligand
COM on the receptor surface in the bound state. The
orientation of the ligand in the binding site can be specified
using the three Euler angles Ω between the receptor frame and
the ligand frame or using alternative angular coordinates based
on a subset of ligand and receptor atoms.15,16 The conforma-
tional state in the binding site can be further specified by
providing a set of internal coordinates χ of the ligand and the
receptor. Overall, a set of translational, orientational, and
conformational coordinates, Y (x) ≡ {R(x),Ω(x),χ(x)}, may be
used to structurally define the complex. From a theoretical
standpoint, this is formally achieved, as we shall see later on, by
defining a Heaviside step function Θ(Y) = 1 in a domain
marking the relevant ligand−receptor coordinates Y for the
associated state.31
In most applications for the determination of the dissociation
free energy using the alchemical method, a set of harmonic
restraints are introduced on the Y set of coordinates to keep the
ligand in the binding pose while the decoupling process
proceeds. The restraint potential in the Y coordinates has the
general form
= − −V x x xY Y K Y Y( ) 1
2
( ( ) ) ( ( ) )tr c c (1)
where K is the diagonal matrix of the harmonic force constants.
Note that the function e−βVr may be interpreted as a non-
normalized multivariate Gaussian distribution in the space
defined by the coordinates Y = {R(x),Ω(x),χ(x)}, i.e.
=β Σ− − − −
−
e eV x x xY Y Y Y( ) 1/2( ( ) ) ( ( ) )
T
r c r
1
c (2)
where the diagonal covariance matrix Σr is defined as
Σ = −k TKr B 1 (3)
The parameter Yc in the restraint potential should be chosen
so as to match the true mean values of vector Y in the
unrestrained complex. In refs 32 and 33 in the context of single
molecule pulling experiments, a simple relation was derived
between the free energy of the driven system (i.e., with
Hamiltonian including the harmonic potential of an external
device coupled to a specific molecular distance R) and the free
energy of the system with unperturbed Hamiltonian along the
driven coordinate (i.e., the potential of mean force along R).
The relation proposed by Marsili (eq 7 in ref 32) can be
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straightforwardly applied to the Y coordinate for any of the
restrained λ alchemical states in DDM as
λ λ
ρ λ
ρ
= + − +
|
*
⎛
⎝⎜
⎞
⎠⎟G G V k TY Y Y Y
Y Y
Y
( , ) ( , ) ( ) ln
( , )
( )r c r c B
r c
(4)
where we have used the subscript r when referring to quantities
of the restrained system and where
∫λ = − β λ− + −G k T xeY( , ) ln[ d ]H x V xY Yr c B [ ( , ) ( ( ) )]r c? (5)
∫
∫
λ
δ
δ
ρ
ρ
= −
−
* −
= −
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β λ
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−
−
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⎢⎢
⎤
⎦
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Y
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Y
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( )
( )
H x
H xB
( , )
( , )
B
(6)
where Gr(Yc,λ) is the free energy of the restrained system (? is
a constant that makes the argument of the logarithm
adimensional) and G(Y,λ) is the free energy of the unrestrained
system at Y with respect to some immaterial reference state at
Y*. In eqs 5 and 6, H(x,λ) is the Hamiltonian at the alchemical
state λ with x encompassing all solvent, ligand, and receptor
coordinates. ρr(Y|Yc,λ) ≡ ⟨δ(Y − Y(x))⟩Yc,λ, finally, is the
canonical probability density evaluated at Y for the system
restrained around Yc with free energy at the alchemical state λ
given by eq 5.
In the alchemical decoupling of the complex (left branch of
the cycle in Figure 1), one computes, via FEP or TI, the free
energy difference between the states at λ = 1 (interacting
ligand) and λ = 0 (noninteracting ligand) subject to the
restraint potential Vr(x) (eq 1). We can express this difference
using general eq 4, thereby obtaining the Y* independent
relation
χ χ χ
χ
χ χ
χ χ
ρ
ρ
Ω Ω Ω
Ω
Ω Ω
Ω Ω
Δ = −
= Δ +
G G G
G k T
R R R
R
R R
R R
( , , ) ( , , , 0) ( , , , 1)
( , , ) ln
( , , , , , 0)
( , , , , , 1)
b
r
c c c b
r
c c c b
r
c c c
B
b
r
c c c
b
r
c c c
(7)
where for the time being the expanded notation Y = {R,Ω,χ}
denotes the set of translational, rotational, and internal ligand−
receptor coordinates. In eq 7, the quantity ΔGbr (Rc,Ωc,χc)
corresponds to decoupling free energy of the restrained
complex, and
∫
∫
χ
χ χ
χ χ
δ δ δ
δ δ δ
Ω
Ω Ω
Ω Ω
Δ
= −
− − −
− − −
β
β
−
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H xB
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(8)
is the decoupling free energy of the unrestrained system
evaluated at Y = {R,Ω,χ}. Note that, because there is no change
in the parameters Yc = {Rc,Ωc,χc} in going from the initial
(coupled) to the final (decoupled) state, correspondingly, there
cannot be a change in the harmonic potential energy at Y =
{R,Ω,χ} due to the restraint.
Similarly, it can be shown that, if we restrain the dissociated
state of the ligand−receptor system (R = ∞) at the rotational/
conformational state Ωc,χc using a harmonic potential, the
decoupling free energy of the ligand in this restrained
dissociated state (i.e., in the right branch of the cycle of Figure
1) is given by
χ χ
χ χ
χ χ
ρ
ρ
Ω Ω
Ω Ω
Ω Ω
Δ = Δ +
|
|∞
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where
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(10)
is the decoupling free energy of the unrestrained ligand in the
unbound state evaluated at R∞,Ω,χ. Here, R∞ represents a
ligand−receptor COM distance that is large enough to allow
the ligand and the receptor to interact only with the solvent
when λ ≠0. Similarly to eq 7, ρur (Ω,χ|Ωc,χc,1) and
ρu
r(Ω,χ|Ωc,χc,0) are the probability densities of the Ω,χ
coordinates for the dissociated (free) ligand, orientationally
and conformationally restrained, evaluated at λ = 1 and λ = 0,
respectively. ΔG(R∞,Ω,χ) in eq 10 represents the reversible
work to bring the ligand in the dissociated state from the bulk
into the gas phase when the system is in the ro-vibrational
states defined by the vector Ω,χ. All relative ligand−receptor
rotational states at R∞ (i.e., for the separated species) have
equal weights 1/8π2 so that ΔG(R∞,Ω,χ) ≡ ΔG(R∞,χ)
depends only on the conformational state χ.
In this regard, we note that the restrained coordinate χ in eqs
7 and 9 may in principle also include conformational
coordinates of the receptor. In such a case, because only the
ligand is annihilated in the right branch of the cycle in Figure 1
(the dissociated state), the alchemical contribution to the
decoupling free energy comes only from the ligand with no
contribution from the χ-restrained unbound protein. Nonethe-
less, as we shall see later on, restraining the conformational
state of the protein indeed has an impact on the alchemically
computed dissociation free energy.
By subtracting eq 10 from eq 8, we obtain
∫
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∫
∫
∫
∫
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where we have exploited the fact that the probability densities
of the decoupled ligand and receptor (λ = 0) are uniform over
R. χΩR( , , )? represents the reversible work for bringing the
separated (R∞) ligand and receptor in the Ω,χ arrangement
into the corresponding bound conformation at R. As the
function χΩR( , , )? for R∞ does not depend on Ω but may
depend on χ, it is convenient to express the reversible work
χΩR( , , )? in terms of potentials of mean force, evaluated
with respect to an arbitrary reference conformational state χ*
for the separated species, i.e.
χ χ χΩ Ω≡ − ∞w wR R R( , , ) ( , , ) ( , )? (12)
with
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In eq 13, w(R∞,χ) represents the reversible work to bring the
separated system from the χ* conformational arrangement to
the new conformational state χ, and w(R,Ω,χ) is the reversible
work to bring the separated system at χ* and with relative
orientation expressed by Ω to the bound state defined by the
coordinates R,Ω,χ.
To close the alchemical thermodynamic cycle, we subtract eq
9 from eq 7 and use eq 11 by setting Y = Yc
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where to remove the excess baggage from the formalism we
have redefined the probability density for the restrained system
as
χ χ χ
χ χ χ
ρ λ ρ λ
ρ λ ρ λ
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≡
≡
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with λ = 0 or λ = 1. Eq 14 expresses the fact that the
dissociation free energy of the restrained system, computed in
alchemical simulations via FEP or TI; namely, the quantity
χ χ χΩ Ω ΩΔ = Δ − Δ ∞G G GR R R( , , ) ( , , ) ( , , )dr c c c b
r
c c c u
r
c c
(16)
is equal to minus the reversible work for forming the complex
plus a correction related to the logarithm of the ratio of the
canonical probability densities for the restrained decoupled and
coupled bound and separated states. It should be stressed that,
for eq 14 to be valid, the canonical probability densities at the
end states, ρb
r (R,Ω,χ|0,1) and ρur (Ω,χ|0,1), must be both
evaluated with the restraint in place. The strength of the
harmonic potentials, restraining the bound state (left branch)
around Rc,Ωc,χc or restraining the rotational/conformational
free ligand (right branch) around Ωc,χc can be set
independently.
How then does the FEP or TI computed DDM dissociation
free energy ΔGdr (Rc,Ωc,χc) of the restrained system relate to the
standard dissociation free energy ΔGd0? Or equivalently, how
does the potential of mean force w(Rc,Ωc,χc) at {Rc,Ωc,χ} relate
to the dissociation constant Kd/C0 = e
−βΔGd
0
? We have seen that
the rotational states Ω, marking the orientation of the ligand in
the binding site, all have equal probability of 1/8π2 when the
molecules are separated in the bulk (no matter what are the
conformational states of the partners). The χ conformational
states of the separated species are in general not uniformly
distributed and can thus be rationalized in terms of conforma-
tional basins with uneven weights. To this end, following ref 21,
we rewrite the dissociation constant in terms of the potential of
mean force w(R,Ω,χ) as
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where J(R,Ω) is the Jacobian of the transformation from
Cartesian to the relative translational orientational coordinates
R,Ω and where Θ(R,Ω,χ) is a Heaviside step function
(sometimes referred as the indicator function14,21,34) defining
the region of existence of the complex between the receptor
and ligand in the R,Ω,χ space. In the second line of eq 17, in
the denominator we have exploited the fact that, as V → ∞
(infinite dilution limit), w(R,Ω,χ) can be taken to be equal to
w(R∞,χ) everywhere so that we can perform the integral on the
R,Ω coordinates obtaining the factor 8π2V. In the last equality,
we have used the definition eq 12 for the reversible work
χΩR( , , )? in terms of the potential of mean force (PMF)
with respect to an arbitrary reference conformational state.
The integral in brackets in the numerator of eq 17 (that has
the dimension of a volume and square radiants) can be
expressed in terms of an effective volume Vb(χ) times the
exponential of the potential of mean force at the point Rχ,Ωχ,χ,
corresponding to the minimum value of the ligand receptor
reversible work function ? given a χ conformation. This
effective binding site volume Vb(χ) depends in the general on
the conformational state χ of the ligand and the receptor. The
same holds true for the minimum value in the R,Ω space of the
reversible work function ? at fixed χ. Conformational states
(e.g., extended vs compact configurations of a flexible ramified
ligand) can be characterized by different inertia moments with
an impact on the size and shape of the volume Vb(χ)). In
particular, Vb(χ) may be equal to zero (or equivalently the
indicator function Θ(R,Ω,χ) is zero everywhere) for conforma-
tional states that are incompatible with the complex. In
summary, given the conformation χ, the choices of the point
Rχ,Ωχ and of the corresponding effective volume Vb(χ) are
intertwined so as to satisfy eq 17.
To define more precisely this χ-dependent effective roto-
translational volume Vb(χ), we rewrite the integral in brackets
in eq 17 with respect to the six external coordinates X = R,Ω
using a multivariate Gaussian distribution of appropriate
covariance Σb(χ), i.e.
∫
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so that
χ χπΩ Σ= | |χ χV J R( ) ( ) (2 ) ( )b 6 b (19)
If we choose a diagonal covariance matrix satisfying eq 19, and
given that the Jacobian has the factorized form J(Rχ,Ωχ) =
JT(Rχ)JΩ(Ωχ), then the volume Vb(χ) may be factored in a
translational and rotational binding site volume
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where ΣbT(χ) and ΣbΩ(χ) are 3 × 3 diagonal covariance matrices
corresponding to the translational and orientational block.
Using eqs 18 and 19, eq 17 may be rearranged as
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expresses the canonical probability density for the χ conforma-
tional state of the separated species.
Suppose now, as schematically depicted in Figure 2, that
function Θ(R,Ω,χ) is nonzero only for Nc disconnected
domains Δχi of the χ coordinates, i.e. that binding can occur
in Nc conformationally distinct poses, each with a roto-
translational volume Vb(χi) around the local minimum of the
PMF at the point Ri,Ωi,χi. Then, by appropriately selecting the
volumes Vb(χi) and the points Ri,Ωi,χi in the Nc conformational
basins, we can rewrite the integral eq 22 as
∑ χ χπ=
χβ Ω−
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where we have defined the conformational weights of the Nc
poses as
∫χ χ χρ= =
χΔ
W i N( ) ( ) d , where 1, 2 ....i c
i (25)
Note that in general we may have that ∑i
Nc W(χi) ≠ 1. This
occurs, as depicted in Figure 2, if only some of all the possible
conformational basins in the domain spanned by the χ
coordinates are involved in binding. Eq 24 was originally
derived by Gallicchio34 (see eqs 19 and 20 of ref 34).
If the binding involves only one conformational state or
basin, i.e., if the indicator function Θ(R,Ω,χ) is nonzero around
the point Rc,Ωc,χc (or equivalently the volume Vb(χ) is nonzero
only within an interval Δχc around the point χc), then we can
write
χ
χ
π
= χ χβ Ω− − ∞
K
W
V
e
1
( )
( )
8
w wR R
d
c
b c
2
[ ( , , ) ( , )]c c c c
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where W(χc) = ∫ Δχc ρ(χ) dχ and Vb(χc) is the roto-translational
binding site volume in the binding conformational basin at χc.
W(χc) can therefore be identified, in first instance, with the
canonical weight in dilute solution of the binding ligand/
receptor conformation for the separated species. If such single
binding conformation has a low weight for the separated
species, then the drug and/or the receptor experiences
substantial conformational changes upon binding, and the
free energy gain in the association process comes either from
the volume (or entropy; see below) term Vb(χ) or from the
s o l v e n t -m ed i a t e d e n t h a l p i c g a i n d u e t o t h e
e−β [w(Rc,Ωc,χc) − w(R∞,χc)] term. The free energy difference that
refers to the separated species at χc and χu (where the latter is
the most favorable conformational state of the separated
species) is called the binding reorganization energy, measuring
energetic strain and entropic factors that oppose binding.35,36
Taking into account that ΔGd0 = −kBT ln(KdV0), eq 26 can be
equivalently written in terms of dissociation free energy as
χ χ
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π
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b c
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Going back to eq 14, eq 27 provides the sought relationship
between the reversible work χΩR( , , )c c c? and the standard
dissociation free energy ΔGd0 in the context of alchemical
theory with restraints. If we use eq 27 in eq 14, and using the
definition eq 16, we finally find
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where we have defined the overall binding site volume as
χ χ χ χ= ΩV V W( ) ( ) ( ) ( )b c T c c c? (29)
Eq 28 is the central result of this paper and provides a
general relation embracing (as we shall see further on) all
current alchemical theories from the DAM approach,10,11 with
(apparently) no restraints, to the Deng and Roux method19
with strong restraints. Eq 28 says that the standard or absolute
dissociation free energy, ΔGd0, is given by the simulation
dissociation free energy on the restrained systems, ΔGdr (Yc),
plus a composite standard state correction due to the allowance
volume and probability density ratios that strictly depends on
the imposed translational and (possibly) orientational/con-
formational harmonic restraints. When restraints on R, Ω, and χ
are imposed, the “translational volume” VT(χc) and the
“rotational volume”, VΩ(χc), defined in eq 21 are both a
function of the restrained conformational coordinates. When
only translational and orientational restraints are imposed, and
the canonical sampling of the accessible conformational space
has been attained for all λ states in either branch of the cycle,
then the volume Vb = VTVΩ has, correspondingly, translational
and orientational components that are independent of the
conformational state in the bound or free state. By the same
Figure 2. Free energy of the separated state, w(R∞,χ), as a function of
the conformational coordinates. Binding conformational basins (for
which Vb(χi) ≠ 0) are indicated in green color.
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token, the probability density ratios in eq 28 become
independent of the (unrestrained) conformational coordinate
χ. If the harmonic restraints are imposed only on translations,
i.e., Y = R, provided that the orientational sampling of the
translationally restrained bound state is canonical for all λ states
in either branch of the cycle, then only the volume VT and the
probability density ratio for bound state alone are needed in the
correction.
Finally, we remark that although the restraining orientational
and conformational parameters Ωc,χc (if present) must be
identical when decoupling the bound and free ligands, the force
constant K can be selected independently. By imposing an
infinitely stiff force constant when decoupling the orientation-
ally and conformationally restrained ligand in bulk, we have that
ρu
r (Ωc,χc|0) = ρur (Ωc,χc|1). Eq 28 can hence be compactly
rewritten as
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with the composite correction term depending only on the
bound state properties and the volume Y( )b c? depending on
the vector Yc, possibly via its conformational components χc.
Deng and Roux’s Theory: Stiff Restraint Regime. When K
→ ∞ also in the bound state, i.e., in the so-called stiff-spring
regime,32,37 the last logarithmic terms on the rhs of eq 28 are
zero because the probability densities for the restrained bound
and free ligands in the λ = 1 and λ = 0 states become identical.
According to eq 14, the alchemically determined dissociation
free energy (eq 16), ΔGdr (Rc,Ωc,χc), can be thus taken to be
equal to minus the reversible work χΩR( , , )? evaluated at
the restraint value {Rc,Ωc,χc}, i.e.
χ χΩ ΩΔ = −
Σ| |→
G R Rlim ( , , ) ( , , )
0
d
r
c c c c c c
r
?
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Using eqs 29 and 31, eq 28 can hence be rearranged as
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The volumes VT(χc) and VΩ(χc) and the factor W(χc) are
related to the oscillations of the R,Ω,χ coordinates when the
ligand and the receptor are in the conformational basin with
minimum χc. As suggested in ref 18, these volumes should be
determined in a preliminary unrestrained simulation of the
complex.38
When imposing strong restraints on R,Ω,χ, it is tacitly
assumed that the ligand can perform only small librations
around the minimum Rc,Ωc,χc defining the binding site and that
the binding state is characterized by a single conformational
pose around χc (i.e., eq 26 holds). One can see the three
logarithmic terms in eq 32 as a translational, rotational, and
conformational entropy loss of the bound state, producing a
penalty in the binding affinity. Hence, the more tightly the
ligand is bound in the pocket, the smaller the “volumes” VT(χ),
VΩ(χ), and W(χ) will be and the larger is the entropy loss due
to association. We may hence say that eq 32 constitutes the
statistical mechanics foundation of a sophisticated docking
approach: the function χΩR( , , )c c c? is evaluated by the
alchemical decoupling of the complex, tightly restrained at
Rc,Ωc,χc, and of the free ligand, tightly restrained at Ωc,χc. In
molecular docking, the solvent averaged energetic contribution,
χΩΔ R( , , )c c c? is evaluated on the end-points using molecular
mechanics Poisson−Boltzmann surface area (MM/PBSA))39,40
or the molecular mechanics-generalized Born surface area
(MM/GBSA)40−42 models, whereas the elusive volume
entropic contributions are evaluated using either MD method-
ologies43,44 or simplified analytic estimates.45
It is important to stress that the size and the units of the
volume χ χ χ χ≡ ΩV V W( ) ( ) ( ) ( )b c T c c c? depends on the choice
of the coordinates Y that are used to define the binding site via
the restraint potential. Provided that χ( )b c? can somehow be
estimated in independent unrestrained simulations of the
complex38 (needed for measuring VT(χ) and VΩ(χc)) and of the
free ligand (needed for measuring W(χc)), eq 32 allows for
computing the absolute dissociation free energy from the
difference of the decoupling free energies of the free ligand and
of the complex obtained by FEP or TI, where the latter is
tightly kept at the Rc,Ωc,χc ligand−receptor position by a set of
strong restraints of the form of eq 1. Although R and Ω are
relative ligand receptor external coordinates involving the
atoms of both species, the χ coordinates in general involve only
atoms of the ligand, typically expressed using dihedral
angles.15,19,23 This is so because when the ligand is annihilated
in the left branch of the alchemical cycle, the free protein must
not experience any restraint. If χ is chosen so as to also include
(or affect) conformational coordinates of the protein, then the
restraint on χ affects the motion (and the sampling) of the
protein when the ligand is annihilated. In such a case, an
unrestrained simulation of the free protein is in principle
necessary to determine the overall conformational weight
W(χc) for the separated species entering eq 32.
Eq 32 was previously derived using a different route by
Boresch et al.15 and by Deng and Roux;19 it does not explicitly
depend on the imposed restraint potential,38 hence resolving
the inconsistency when one lets the volume Vr (i.e., in the stiff
restraint limit) go to zero in the Gilson’s standard state
correction term kBT ln(Vr/V0). In the strong restraint approach,
however, the estimate of the dissociation free energy crucially
depends on the estimate of the unknown binding site volume
χ( )b c? that can vary by several kcal mol−1,
19 hence spanning
more than 3 orders of magnitude in the inhibition constant.
Moreover, the parameters Yc in the restraint potential, eq 1,
should be preferentially chosen such that they coincide with the
corresponding mean values of the unrestrained bound state Yc
= ⟨Y⟩b, where the subscript b indicates that the mean must be
taken over the canonical configurations of the bound state. If
any of the Yi
c components of the Yc vector differ from the
corresponding equilibrium value ⟨Yi⟩b, then the alchemically
decoupling system is subject to a systematic strain potential that
will be reflected in the computed reversible work Y( )? .
Most likely, as noted in ref 16, the major weakness in DDM
with strong restraints lies in the choice of the restrained
coordinates themselves, that impact the size and units of
χ( )b c? . First of all, the number and nature of ligand and
receptor conformational coordinates participating in binding is
not known from the start. Second, regardless of the choice,
because of the inherent conformational flexibility of many
ligands and of virtually all receptors, these coordinates will be
coupled to other ligand and receptor coordinates such that
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restraining them may make it harder or even prevent sampling
of configurational states that are relevant for binding. In some
sense, DDM theory with strong restraints appears essentially to
be based on the traditional picture of a “lock and key” model46
with a systematic underestimation of receptor and ligand
conformational reshaping upon binding (“induced fit”
model47).
Gilson, Bush, Given, and McCammon theory: Intermedi-
ate Restraint Regime. We now assume that we impose only
translational and orientational restraints and that these
restraints, when applied to the bound state (left branch of
the cycle), are weak enough to allow the ligand−receptor
system to canonically sample all χ conformational states that are
important for binding. We then set an infinitely stiff
orientational restraint in the right branch of the cycle so that
eq 30 can be used, i.e.
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where the binding site volume Vb = VT VΩ accounts for
translational and rotational contribution. The probability
density of the restrained fully decoupled ligand in the binding
site, ρb
r (Rc,Ωc|0) ≡ ρbr (Yc|0) is given by
∫
ρ | = =
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where we have used eqs 1 and 3 and Vr ≡ Vr(Σr) defines the
temperature-dependent allowance restraint volume such that Vr
contains the unknown roto-translational binding site volume
Vb.
The probability density of the fully coupled restrained bound
state, ρb
r (Rc,Ωc|1) ≡ ρbr (Yc|1), can be written in terms of a
product of two multivariate Gaussian distributions48 with
covariance matrix Σ−1 = Σb−1 + Σr−1 defined in the Y = {R,Ω}
space, i.e.
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where we have set Σb so that
∫ ∫=β β Σ− − − − −−e J e J eY Y Y( ) d ( )
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with π Σ= | |V J Y( ) 2b c 6 b . The effective covariance Σb defining
the volume Vb no longer depends on the conformational states,
whose contribution is supposed to be implicitly integrated away
in the PMF w(R,Ω). Inserting eqs 35 and 34 into eq 33, we find
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In the assumption that the last term is small and can be
neglected (i.e., Vr ≫ Vb), and factoring the restraint volume Vr
in translational and orientational parts VI,ξI, then eq 36 is
identical to the equation proposed by Gilson.49 Note also that,
when Vr≪ Vb, the probability density at Yc of the fully coupled
bound state, ρ(Yc|1) (eq 35), becomes identical to that of the
fully decoupled bound state, ρ(Yc|0), thus recovering the stiff
regime result involving Vb only (i.e., obtaining eq 32 lacking the
conformational term).
As stated shown in ref 18, “[the choice of the harmonic force
constant in the restraint potential] raises important questions as
to how sensitive are the calculated free energies to the strength
of the restraining potentials and whether an arbitrary choice of
k [the force constant of the restraint ] would yield the correct
results.” With this regard, eq 36 establishes a “precise statistical
mechanics definition of the restraining potential”18 in terms of a
ratio between the known restraint volume Vr and the
underlying binding site volume Vb and of its impact on the
alchemically computed standard dissociation free energy. In
particular, as conjectured in ref 14 and computationally verified
in ref 34, if we increase Vr (or equivalently if we decrease the
ligand concentration) by weakening the restraint, the
corresponding gain in the dissociation energy due to the
logarithmic term in eq 36 should be exactly compensated by a
decrease in the free energy ΔGdr (Rc,Ωc), provided that in the
simulation of the restrained complex all states that are made
accessible by the weakened restrained potential have been
canonically sampled for all λ states along the alchemical path.
Because of this compensation, eq 36 becomes in principle
independent of the arbitrary choice of Vr when Vr ≫ Vb,
allowing for computation of the absolute dissociation free
energy without knowing the underlying binding site volume Vb.
On the other hand, DDM with weak restraint potentials
should be handled with due care by practitioners. In the case of
highly symmetric ligands like benzene bound to T-lysozime,19
for example, orientational restraints may prevent the sampling
of the bound conformations that are defined by a mere
exchange of the atom labels due to rotational operations of the
symmetry group of the ligand (say σ), underestimating the
orientational volume in the bound state and hence the
dissociation free energy. If the orientational restraint prevents
the sampling of any of the equivalent σ = 12 states of benzene,
then the free energy should be corrected by an additive volume
term kBT ln 12 apparently due to “symmetry”.
50,51 If instead the
restraints are engineered so that they allow the sampling of the
bound states that are generated by rotations around the 6-fold
axis of the benzene molecule but not of those that can be
generated by rotation around the 2-fold symmetry axis, then the
correction factor reduces to kBT ln 2. Symmetry numbers
therefore enter into Gilson’s theory as volume correction
factors. In other words, the imposed restraint may prevent the
sampling of an orientationally equivalent configuration, even if
only a translational restraint is imposed. In the case of the
benzene ligand, if the restraint on R is too tight (or the
simulation too short), then the ligand may not be allowed to
partially leave the binding pocket so that it can rotate around
the symmetry axis to sample different configuration of the atom
labels, i.e., to visit the underlying orientational volume VΩ.
This kind of “symmetry” correction should also apply to the
Deng and Roux DDM variant with strong restraints if Vb(Ωχ)
was estimated from the librations of the unrestrained ligand in
just one of the equivalent orientational poses, thus under-
estimating the actual orientational volume.
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Jorgensen’s Theory: Unrestrained (DAM) Regime. What
happens when we instead let the force constant K → 0 in eqs
28 and 30? The ligand in unrestrained simulations is mistakenly
considered as “free to wander”, whereas actually its
concentration (or restraint volume Vbox) is externally imposed
by the periodic boundary conditions (PBC) used in the
simulation. As noted in refs 15 and 23, the resulting Vbox-
dependent free energy should hence be related to the standard
dissociation free energy as
Δ = Δ +G G k T V
V
(DAM) lnd
0
B
box
0 (37)
This result can be obtained by applying the K → 0 limit of
general eq 30 and assuming that only a restraint on R is
imposed in the left branch of the cycle, i.e.
ρ
ρ
Δ = Δ + −
|
|Σ| |→
⎜ ⎟
⎡
⎣
⎢⎢
⎛
⎝
⎞
⎠
⎤
⎦
⎥⎥G G k T
V
V
k TR
R
R
lim ( ) ln ln
( 0)
( 1)
T
d
0
0
d
r
c B 0 B
b
r
c
b
r
c
(38)
where VT = e
βw(Rc) ∫ Vbe
−βw(R)J(R) dR is the allowance oscillation
volume of the COM vector distance R in the complex
irrespective of the ligand−receptor orientational and conforma-
tional coordinates. In the limit |Σ| → 0, the restraint the
probability density of the decoupled ligand in bound state is
uniform and is given by
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The probability density of the coupled system at R = Rc, ρb
r (Rc|
1) is simply given by
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where we have used the fact that ∫ Vboxe
−βw(R)J(R) dR =
∫ Vbe
−βw(R)J(R) dR + Vbox − VT and where the constant
= ≃β β− − Δ
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c e eV V
V
w V
V
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r
( ) ( )box T
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0 can be neglected as long as
eβΔG
0
≫ Vbox/V0. Plugging eqs 40 and 39 into eq 38, and
defining ΔGd(DAM) = lim|Σ |→0 ΔGbr (Rc) − ΔGu, we finally
recover eq 37.
DAM theory indeed has a “restraint translational volume”
that sets the ligand concentration to 1/Vbox, so that, when
supplemented with the standard state correction ( )k T ln VVB r0 , it
becomes a particular case of the Gilson theory, eq 36, with Vr =
Vbox. On the other hand, eq 37 holds if (i) the simulations are
converged for all λ states and (ii) the MD box volume is such
that eβΔG
0
≫ Vbox/V0. Although the second proviso is usually
met in alchemical simulations for tight binding ligands (Kd < 1
μM), as pointed out in refs 15 and 23, convergence of an
unrestrained ligand−receptor subject only to PBC is simply out
of reach given the present computing power.52 Nonetheless, as
discussed in the Introduction, the unrestrained DAM approach
is still used in ligand−receptor systems,25,27 providing in
general good estimates of the dissociation free energies. In this
regard, it has been recently proposed,9,53,54 that these
unrestrained DAM simulations actually express a nonequili-
brium measure of the dissociation free energy that is close to
the real equilibrium value because of well-grounded theoretical
reasons stemming from nonequilibrium thermodynamics.
■ CONCLUSIONS
In this paper, the statistical mechanics of noncovalent bonding
in drug−receptor systems has been revisited. It has been shown
that all existing alchemical theories in binding free energy
calculations can be rationalized in terms of a unifying treatment
encompassing the original unrestrained DAM,10,11 the Gilson’s
restrained DDM variant,14 and the sophisticated docking
approach proposed by Deng and Roux.19 According to general
eq 30 relating the alchemically determined free energy
difference to the standard dissociation free energy, the cited
alchemical theories differ in the definition (explicit or implicit)
of the binding site volume through the enforcement of a set of
appropriately selected restraint potentials.
The strong restraint approach19 evaluates the potential of
mean force at the bottom of the well Yc, relying on a precise
knowledge of the binding pose volume Vb entering in the
standard state correction. As such, the Deng and Roux
alchemical theory can be considered as a sophisticated docking
approach where only a single pose is assessed in the context of
the traditional picture of the lock and key model (see Figure 3).
The strong restraint approach, by limiting the sampling space, is
in general assumed to converge more easily.19 On the other
hand, we have seen that this methodology may underestimate
the effective binding site volume by preventing the sampling of
conformational states that are important for binding.
Figure 3. Lock and key model (left) and induced fit model (right) for the PMF in the binding site domain in the Y coordinates for the associated
state.
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In the intermediate regime, conformational (and possibly
orientational as well) restraints are lifted, and restraints on
external coordinates are weakened so that the ligand can now
move in the binding pocket within a volume Vr without drifting
off in the bulk. In this case, provided that Vr contains the
underlying binding site volume Vb, eq 30 becomes equivalent to
the Gilson formula eq 36 with Vb being replaced by the
parameter Vr in the standard state correction. In the
intermediate regime, the dissociation free energy estimate is
in principle independent of the chosen parameter Vr due to the
compensation effect on the alchemical free energy difference
ΔGb − ΔGu when Vr is made larger, given that the simulations
have converged at all λ states.
When the force constant of the restraint potential is made
infinitely small, only the translational restraints imposed by the
PBC survives. The ligand must hence sample all states that are
made accessible at the concentration 1/Vbox in all λ
thermodynamic states, possibly including a fraction of unbound
states at λ = 1. Alchemical decoupling becomes cumbersome,
and the DDM theory becomes equivalent to the DAM theory
provided that the standard state correction kBT ln(Vbox/V
0) is
used and that eβΔG
0
≫ Vbox/V0. DAM, although it may be
considered as a special case of the Gilson’s DDM theory with Vr
= Vbox, is not viable in practice due to the difficulties in the
sampling of ligand−receptor configurations in the entire
simulation box for all λ thermodynamic states.
If the restraint is weak and involves only the translational
coordinate R, the ligand−receptor PMF and the underlying
binding site volume Vb ≡ VT are modulated by the ro-
vibrational coordinates of both the ligand and the receptor, as
schematically depicted in Figure 3. As first remarked in ref 14,
the integral defining the equilibrium constant in terms of the
exponential of the PMF can be extended beyond the domain
where the indicator function is equal to one with no appreciable
change in Kd. It then follows that Kd depends only weakly on
the specific definition of Vb, provided that such a domain
includes all of the important R,Ω regions of the binding site
volume.14,34,55
The use of a weak restraint in the context of the alchemical
theory implies weaker assumptions on the pose topology and
nature, hence progressively shifting the approach toward a
more realistic induced fit/conformational proofreading model
in drug−receptor interactions. As remarked in the seminal
papers of refs 14 and 19, the price to pay is that the choice of a
larger Vr expands the sampling of the accessible ligand−
receptor configurational space in the left branch of the
alchemical cycle to regions of low PMF yielding a negligible
contribution to the dissociation constant. These regions,
however, may be the only access to the sampling alternate
low free energy poses contributing to binding. This sampling
expansion in DDM with weak restraints may be more relevant
for the low value of the alchemical coupling parameter λ (when
the ligand starts to be loosely bound to the binding site),
making the overall convergence of the FEP or TI simulation
harder.
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